Nestor Basic Drugs Limited - Company Profile

It is a business services public limited company based in New Delhi, Delhi, India, established in 1995.
1995 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Nestor Basic Drugs Limited

Nestor Basic Drugs Limited, a struck off public limited company, was established on 31 July 1995 in New Delhi, Delhi, India. it holds CIN: U74899DL1995PLC071315. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Rahul Sehgal (Director), Prashant Sehgal (Director), Mehar Sehgal (Director). Past directors included Saiffudin Taherali Hathiari, Rajiv Sehgal. Its latest AGM occurred on 16 August 2013, with the balance sheet filed on 31 March 2013. It is based at B-24/3 Okhla Industrial Area Phase Ii, New Delhi, Delhi, 110020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1995PLC071315

  • Registration Number

    071315

  • Incorporation Date

    31 July 1995

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Nestor Basic Drugs Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Nestor Basic Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nestor Basic Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Sehgal Director 31 Oct 2009 Current
Prashant Sehgal Director 31 Oct 2009 Current
Mehar Sehgal Director 18 May 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Nov 2009 Past
Pramod Abcsdd Director 02 Nov 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nestor Basic Drugs.

Enhance accessibility to Nestor Basic Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nestor Basic Drugs revenue growth over time
Nestor Basic Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nestor Basic Drugs?

Unlock access to Nestor Basic Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nestor Basic Drugs?

Unlock and access historical data on people associated with Nestor Basic Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nestor Basic Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nestor Basic Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nestor Basic Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nestor Basic Drugs Limited last Annual general meeting of members was held on 16 Aug 2013 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nestor Basic Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Rahul Sehgal was appointed as a Director was appointed as a Director on 31 Oct 2009 & has been associated with this company since 16 years 8 months . was documented.

  • Director Appointment

    Prashant Sehgal was appointed as a Director was appointed as a Director on 31 Oct 2009 & has been associated with this company since 16 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Mehar Sehgal was appointed as a Director was appointed as a Director on 18 May 2006 & has been associated with this company since 20 years 1 month . was completed.

  • Company Incorporation

    The activity Nestor Basic Drugs Limited was registered on 31 Jul 1995 with Roc Delhi & aged 30 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nestor Basic Drugs Limited?

The CIN of Nestor Basic Drugs Limited is U74899DL1995PLC071315.

Where is Nestor Basic Drugs Limited headquartered?

Nestor Basic Drugs Limited is headquartered at B-24/3 Okhla Industrial Area Phase Ii, New Delhi, Delhi, 110020.

When was Nestor Basic Drugs Limited incorporated?

Nestor Basic Drugs Limited was incorporated on 31 July 1995.

Who are the current directors of Nestor Basic Drugs Limited?

The current directors of Nestor Basic Drugs Limited are

Is Nestor Basic Drugs Limited a listed company?

Nestor Basic Drugs Limited is unlisted.

What is the capital structure of Nestor Basic Drugs Limited?

The authorized capital of Nestor Basic Drugs Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available